After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the day higher.
Equity benchmark indices were seen held steady gains in Wednesday's deals amid mixed cues from global peers.
At the closing bell, the BSE Sensex stood higher by 354 points (0.4%).
Meanwhile, the NSE Nifty closed higher by 92 points (up 0.4%).
Coal India, BPCL and ITC were among the top gainers today.
Cipla, HDFC Life and Maruti Suzuki on the other hand, were among the top losers today.
For a comprehensive overview of key players in the financial sector, check out list of Fin Nifty Companies.
The GIFT Nifty ended at 22,820 down by 62 points or 0.3% lower.
For impact of the Bank Nifty companies and comprehensive overview of the index, check out Equitymaster's Bank Nifty Companies list.
Broader markets ended the day higher. The BSE Mid Cap ended 0.9% higher and the BSE Small Cap index ended 0.5% higher.
Sector indices were trading positive, with stocks in oil & gas sector, realty sector, and power sector witnessing buying.
Eicher Motors, KSB and SRF hit their respective 52-week highs today.
Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...
The rupee is trading at 83.2 against the US$.
Gold prices for the latest contract on MCX are trading marginally higher at Rs 71,412 per 10 grams.
Meanwhile, silver prices are trading 0.2% higher at Rs 82,647 per 1 kg.
Speaking of stock markets, green hydrogen is the infinitely sustainable result of the sun's radiation. So, the shift to hydrogen for fuel is simply a shift away from depleting finite sources of fossil fuels.
Green hydrogen can be a game changer for India, which imports 85% of its oil and 53% of gas demand.
Co-head of Research at Equitymaster, Tanushree Banerjee talks What kind of companies are helping India in this green hydrogen landscape, in her latest video.
Tune in to the below video:
In news from the auto sector, Maruti Suzuki on 10 April said that it has increased prices of Swift and selected variants of Grand Vitara Sigma effective today.
Prices of Swift have been raised by up to Rs 25,000 and Grand Vitara Sigma variant by Rs 19,000.
This comes after the leading automaker announced a price hike across models to the tune of 0.5% in January, citing increased cost pressure driven by overall inflation and increased commodity prices.
Earlier, Maruti Suzuki said that it had achieved a total sales figure of 187,196 units, combining both domestic and international markets in March.
Domestic sales reached 156,330 units, marking a 14% increase compared to March 2023. Additionally, the company sold 4,974 units to other Original Equipment Manufacturers (OEMs) and exported 25,892 units.
In the financial year 2023-24, Maruti Suzuki achieved its highest-ever total sales, reaching 2,135,323 units.
This includes domestic sales of 1,793,644 units and exports totalling 283,067 units.
Maruti Suzuki is India's largest passenger car maker, with a 44% market share in the passenger car segment. It is responsible for starting the automobile revolution in the country.
For more details, check out Maruti's New Technology Might Forever Alter the Electric Vehicle (EV) Market.
It is also among the Top 3 Auto Stocks Leading India's Vehicle Scrapping Revolution.
Moving on to news from the pharma sector, Shares of Sun Pharma Advanced Research Company (SPARC) fell 5% to hit the lower circuit on 10 April after the Mumbai-based pharma company said it was abandoning Phase 2 study on Vodobatinib for Parkinson's.
The PROSEEK study was a global trial that enrolled 513 patients with early Parkinson's disease from the United States, Europe, and India.
It was designed to evaluate the safety and efficacy of the selective c-Abl tyrosine kinase inhibitor in patients with early Parkinson's disease.
The primary goal of the study was to show an improvement in the symptoms, as measured by the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III.
However, the interim analysis, based on data from 442 patients who completed 40 weeks of treatment, failed to demonstrate the superiority of Vodobatinib compared to placebo in the primary endpoint.
It plans to complete the full analysis of clinical outcomes and correlative biomarker data in the coming months.
Moving on to news from the finance sector, the National Housing Bank (NHB) plans to raise up to Rs 30 bn by floating bonds with 3-year-2-month-20-day maturity, people familiar with the development said.
The bonds have a base issue size of Rs 10 bn and a greenshoe option of Rs 20 bn. A greenshoe option gives the underwriter the right to sell investors more bonds than planned if the demand is higher than expected.
The bidding for the bonds will take place on 12 April between 11 am and 12:30 pm on the electronic bidding platform of the National Stock Exchange of India.
The pay-in date of the bonds is 16 April. Pay-in date is the date when the exchange of money and bonds takes place between issuers and investors.
On April 8, HDB Financial Services raised Rs 5 bn through bonds. Money markets were closed on 9 April on account of Gudhi Padwa.
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Today Ends 354 Points Higher | Nifty Above 22,750 | Data Pattern Rallies 12%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!